Clinical trial Recruiting at 4 sites Observational Ages Any age to 40 Weeks

Improving early detection of cerebral palsy in infants in Ireland

Official title: Early Detection & Intervention of Cerebral Palsy in Ireland

Run by University College Cork · NCT05907837 · Data updated 2026-11-12

This study is trying to find out if a new way of checking for cerebral palsy can help doctors spot it earlier in high-risk infants in Ireland.

More Cerebral Palsy trials

Quick facts

Study typeObservational
AgesAny age to 40 Weeks
SexAll
Enrollment1500 (estimated)
SponsorUniversity College Cork
Academic / other
Locations5 sites (Cork and 4 other locations)
StatusRecruiting
StartedJuly 1, 2023
Main results expectedJune 30, 2027
Study endsJune 30, 2028
Registry record updatedOctober 2, 2023
Trial IDNCT05907837 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are high-risk infants, including those born preterm or with neurological risk factors.

Probably not a fit

Patients who do not meet the high-risk criteria or those who pass away before discharge from the neonatal unit may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project focuses on enhancing the early detection of cerebral palsy (CP) in high-risk infants in Ireland. By implementing an evidence-based follow-up approach, the study aims to identify CP and related neurodevelopmental impairments earlier than the typical diagnosis age of 24 to 29 months. The initiative targets preterm infants and those with neurological risk factors, leveraging the critical window of brain plasticity in early childhood for effective intervention. The study will involve collaboration among several maternity hospitals to ensure comprehensive data collection and analysis.

Why it matters

Potential benefit: If successful, this initiative could lead to earlier interventions for infants at risk of cerebral palsy, improving their long-term outcomes.

How similar studies have gone: Other studies have shown promise in early detection and intervention for neurodevelopmental disorders, suggesting that this approach could be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Legal guardians must be able and willing to give written informed consent and to comply with the requirements of this study protocol.
* All infants considered high risk for cerebral palsy and neuro-developmental impairment will be eligible, specifically including:

  * All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight
  * All encephalopathic infants
  * Neurological risk factors (e.g., injury/malformation on neuroimaging, persistently abnormal neurological exam)

Exclusion Criteria:

* Death prior to discharge from the neonatal unit.

Where it's running

  • Cork University Maternity Hospital
    Cork, Ireland
    Recruiting
  • Coombe Women and Infants University Hospital
    Dublin, Ireland
    Recruiting
  • National Maternity Hospital
    Dublin, Ireland
    Recruiting
  • The Rotunda Hospital
    Dublin, Ireland
    Recruiting
  • University Maternity Hospital Limerick
    Limerick, Ireland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.